Earnings Date: July 29, 2026 (Before Market Open) Prepared: July 28, 2026
Key Takeaway: The setup is mixed — consensus is a manageable bar after Q1's massive beat, but the stock has given back -22.7% since earnings (vs XLI +7.4%, SPY +4.1%), suggesting the market is skeptical about the pace of data center revenue conversion and residential recovery. The wildcard is whether GNRC can confirm the June 2 hyperscale supply agreement is translating into Q2 revenue and provide an updated backlog figure.
Q2 2026 consensus calls for ~9–10% revenue growth (in line with management's own guide), driven entirely by C&I/data center, with residential roughly flat. After Q1's massive EPS beat (+$0.47 vs consensus), the bar is reset higher and the market will be focused on whether data center revenue is actually flowing through — the June 2 hyperscale supply agreement and the Sussex facility pulling forward to Q3 are key catalysts. Estimate revisions have been minimal since Q1 (revenue consensus barely moved, EPS up slightly), suggesting the Street is waiting for confirmation rather than getting ahead of the story. The stock's -22.7% decline since Q1 earnings (vs XLI +7.4%) reflects a valuation reset and BofA PT cut, not a fundamental deterioration — creating a potentially interesting setup if Q2 confirms the data center ramp. The wildcard is the backlog update: at Q1 it was >$700M (up ~$300M in one quarter); any further acceleration or a formal hyperscale contract announcement would be a significant positive catalyst.
Key Takeaway: Consensus is a manageable bar on revenue (in line with guidance), but EPS expectations are elevated vs. prior year. The bigger swing factor is C&I segment revenue and EBITDA margin — both need to confirm the data center ramp is real.
KPI | Q1 2026 Actual | Q2 2025 Actual | Q2 2026 Consensus | YoY Change | Guidance | Consensus vs. Guidance |
Net Sales ($M) | $1,059.4M | $1,061.2M | $1,180.0M | +11.2% | ~9–10% growth (~$1,165–1,168M) | +1.0% above midpoint |
Net Sales — C&I ($M) | $510.1M | $430.6M | $535.4M | +24.3% | Mid-to-high 20% growth | In line |
Net Sales — Residential ($M) | $552.2M | $634.7M | $648.5M | +2.2% | ~10% growth | In line |
Adj. EBITDA ($M) | $193.5M | $187.6M | $216.9M | +15.6% | ~18% range | In line |
Adj. EBITDA Margin (%) | 18.3% | 17.7% | 18.4% | +70bps | ~18% range | +40bps above midpoint |
Gross Margin (%) | 38.7% | 39.3% | 38.7% | -60bps | 38.5–39.5% FY range | In range |
Diluted EPS — Operating | $1.80 | $1.65 | $2.01 | +21.8% | N/A (no Q2 EPS guide) | N/A |
Free Cash Flow ($M) | $89.9M | $14.5M | $65.8M | +354% | ~$350M FY | Tracking |
Source: Visible Alpha consensus as of July 28, 2026. Q2 2026 guidance from Q1 2026 earnings call (April 29, 2026).
Quarter | Net Sales Reported | Net Sales Consensus | Revenue Surprise | Revenue Result | EPS Reported | EPS Consensus | EPS Surprise | EPS Result |
Q1 2026 | $1,059.4M | $1,047.5M | +1.1% | Beat | $1.80 | $1.33 | +35.3% | Large Beat |
Q4 2025 | $1,091.5M | $1,159.9M | -5.9% | Miss | $1.61 | $1.76 | -8.5% | Miss |
Q3 2025 | $1,114.4M | $1,192.9M | -6.6% | Miss | $1.83 | $2.22 | -17.6% | Miss |
Q2 2025 | $1,061.2M | $1,026.8M | +3.3% | Beat | $1.65 | $1.32 | +25.0% | Beat |
Q1 2025 | $942.1M | $919.4M | +2.5% | Beat | $1.26 | $0.99 | +27.3% | Beat |
Q4 2024 | $1,234.8M | $1,243.4M | -0.7% | Slight Miss | $2.80 | $2.52 | +11.1% | Beat |
Q3 2024 | $1,173.6M | $1,162.5M | +1.0% | Beat | $2.25 | $1.99 | +13.1% | Beat |
Q2 2024 | $998.2M | $999.9M | -0.2% | In Line | $1.35 | $1.22 | +10.7% | Beat |
Pattern: GNRC has a strong EPS beat history (7 of 8 quarters), but revenue has been more mixed — the Q3/Q4 2025 misses were driven by the weak outage environment. Q1 2026's massive EPS beat (+35%) was driven by cost savings and margin expansion, not just revenue. The Street has historically underestimated GNRC's margin leverage.
Key Takeaway: Management raised FY 2026 guidance on the Q1 call and has made no formal revisions since. The June 2 hyperscale supply agreement and June 15 Belvidere facility acquisition are positive incremental developments but did not come with updated financial guidance.
Metric | Initial Guidance (Q1 2026 Call, Apr 29) | Revised Guidance | Current Consensus | Note |
FY 2026 Net Sales Growth | Mid-to-high teens % | — | ~$4.93B (+15.5% YoY) | No formal revision since Q1 call |
Q2 2026 Net Sales Growth | ~9–10% | — | ~$1.18B (+11.2% YoY) | Consensus slightly above guidance midpoint |
FY 2026 Adj. EBITDA Margin | 18.5–19.5% | — | 19.1% | Consensus at midpoint |
FY 2026 Gross Margin | 38.5–39.5% | — | 38.9% | In range |
FY 2026 Free Cash Flow | ~$350M | — | ~$360M | Consensus slightly above |
C&I Segment Growth | Mid-to-high 20% | — | ~$2.21B (+24.5% YoY) | In line with guidance |
Residential Segment Growth | ~10% | — | ~$2.73B (+10.0% YoY) | In line with guidance |
Q2 2026 Adj. EBITDA Margin | ~18% range | — | 18.4% | Slightly above guidance |
Key Takeaway: Estimates have been remarkably stable since Q1 earnings — the Street is essentially holding guidance midpoints and waiting for Q2 confirmation. The lack of upward revision despite the June 2 hyperscale deal suggests analysts are treating it as a 2027+ revenue event rather than a near-term catalyst.
KPI | Period | Estimate (May 6, 2026) | Current Consensus | Estimate Δ (%) | Initial Guidance (Q1 Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance |
Net Sales | Q2 2026 | $1,177.7M | $1,180.0M | +0.2% | ~$1,165–1,168M | Unchanged | — | +1.0% above midpoint |
Net Sales | FY 2026 | $4,922.9M | $4,927.2M | +0.1% | Mid-to-high teens | Unchanged | — | In line |
Adj. EBITDA Margin | Q2 2026 | 18.3% | 18.4% | +10bps | ~18% range | Unchanged | — | +40bps above midpoint |
Adj. EBITDA Margin | FY 2026 | 19.1% | 19.1% | Flat | 18.5–19.5% | Unchanged | — | At midpoint |
Diluted EPS — Operating | Q2 2026 | $1.97 | $2.01 | +2.0% | N/A | N/A | — | N/A |
Diluted EPS — Operating | FY 2026 | $8.93 | $8.94 | +0.1% | N/A | N/A | — | N/A |
The near-zero estimate revisions since Q1 are notable — the June 2 hyperscale supply agreement announcement (which sent the stock up ~8% on the day) did not translate into meaningful estimate upgrades. This suggests the Street is treating the deal as a 2027+ revenue event rather than a Q2/Q3 2026 catalyst, which could create upside if management provides more specific near-term revenue guidance on the Q2 call.
Source: Visible Alpha consensus. Estimate baseline as of May 6, 2026 (5 trading days post Q1 earnings). Current consensus as of July 28, 2026.
Key Takeaway: GNRC has dramatically underperformed since Q1 earnings (-22.7% vs XLI +7.4%, SPY +4.1%), driven by a valuation reset and pre-earnings risk reduction — not a fundamental deterioration. The stock briefly rallied to +17% above Q1 earnings close on the June 2 hyperscale deal before reversing sharply.
GNRC vs XLI (Industrials ETF) vs S&P 500 — Indexed to 100 at Q1 2026 Earnings (Apr 29, 2026). Key events: June 2 Hyperscale Supply Agreement (orange), June 15 Belvidere IL Facility Acquisition (green). Source: Stock Price Data.
Key Takeaway: Peer commentary from Q1 2026 earnings calls (reported after GNRC's Q1 on April 29) is uniformly bullish on data center power demand — Eaton, Caterpillar, and Cummins all raised their power generation outlooks and described accelerating order activity. This is a strong positive read-through for GNRC's C&I/data center segment. Enphase's Q2 2026 results (reported July 28) show continued pressure in US residential solar/storage, a modest negative read-through for GNRC's residential energy technology segment.
Key Takeaway: The June 2 hyperscale supply agreement is the most significant development since Q1 earnings — it validates GNRC's data center pivot and confirms vendor approval progress. The Belvidere facility acquisition (June 15) demonstrates continued capacity investment to meet accelerating demand.
Key Takeaway: CEO Aaron Jagdfeld has been selling shares on a regular 10b5-1 plan (5,000 shares/month), which is routine and not a signal. No open-market discretionary buys from any insider since Q1 earnings — notable absence given the stock's -22.7% decline.
Name | Title | Transaction Type | Shares | Value (Approx.) | Filing Date | Note |
Aaron Jagdfeld | CEO | 10b5-1 Planned Sale | 5,000 | ~$986K | July 2, 2026 | Routine monthly 10b5-1 plan; 3rd consecutive month |
Norman P. Taffe | President, Generac Home | Option Exercise + Sale | 550 (net) | ~$109K | July 7, 2026 | Exercise of stock options + sale; 10b5-1 plan |
Aaron Jagdfeld | CEO | 10b5-1 Planned Sale | 5,000 | ~$1.43M | June 3, 2026 | Routine monthly 10b5-1 plan |
Norman P. Taffe | President, Generac Home | Option Exercise + Sale | 550 (net) | ~$144K | June 8, 2026 | Exercise of stock options + sale; 10b5-1 plan |
Aaron Jagdfeld | CEO | 10b5-1 Planned Sale | 5,000 | ~$1.30M | May 5, 2026 | Routine monthly 10b5-1 plan |
Multiple Directors (7) | Board | Equity Award | 699–825 each | N/A | May 5, 2026 | Annual director equity compensation grants; not open-market |
All insider sales are 10b5-1 planned sales — pre-scheduled and not discretionary. The CEO's consistent 5,000 share/month sales are routine. The notable signal is the absence of any open-market buying despite the stock's -22.7% decline since Q1 earnings — insiders are not stepping in to buy the dip, which is a mild negative signal but not alarming given the 10b5-1 plan context.
Source: SEC Form 4 filings via Insider Transaction Data.